Friday, Oct 09th

Last update03:12:59 AM GMT

You are here News Health FDA ignored debris in syringes

FDA ignored debris in syringes

E-mail Print PDF

Months before an Angier company shipped deadly bacteria-tainted drugs, the federal Food and Drug Administration received numerous complaints about sediment and debris in the medicine.

The FDA received reports about AM2PAT as early as 2005, but not until December 2007 did the agency issue recall notices to pull the drugs off the market.

Two men pleaded guilty in U.S. District Court this week for their roles in the scheme, which involved falsifying documents to make it appear that proper sterility tests had been conducted. The company’s president, Dushyant Patel, faces 10 charges, but he has not been arrested.


Most Recent Related Stories...

Obama signs bill preventing healthcare cost increase

ObamaPresident Obama signed changes into Obamacare preventing health insurance premium increases for millions.The rare bipartisan changes,...

California governor signs assisted suicide bill

California assisted suicide bill signedCalifornia will become the fifth state to allow terminally ill patients to legally end their lives...

FDA approves new treatment for advanced lung cancer

new lung cancer drugThe Food and Drug Administration approved a new drug for patients with advanced non-small cell lung...

Scientists share Nobel Prize for medicine for anti-parasite drugs

Nobel in medicineThree scientists from Japan, China and Ireland whose discoveries led to the development of potent new...
America's # 1 Enemy
Tee Shirt
& Help Support!
TVNL Tee Shirt
Conserve our Planet
& Help Support!
Get your 9/11 & Media
Deception Dollars
& Help Support!
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!